BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 33921711)

  • 1. Elevated M-MDSCs in Circulation Are Indicative of Poor Prognosis in Diffuse Large B-Cell Lymphoma Patients.
    Wang Z; Jiang R; Li Q; Wang H; Tao Q; Zhai Z
    J Clin Med; 2021 Apr; 10(8):. PubMed ID: 33921711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surface TREM2 on circulating M-MDSCs as a novel prognostic factor for adults with treatment-naïve diffuse large B-cell lymphoma.
    Wang HY; Yang FC; Yang CF; Liu YC; Ko PS; Li CJ; Tsai CK; Chung YL; Chen NJ
    Exp Hematol Oncol; 2023 Apr; 12(1):35. PubMed ID: 37029450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated circulating myeloid-derived suppressor cells associated with poor prognosis in B-cell non-Hodgkin's lymphoma patients.
    Wang Y; Wang J; Zhu F; Wang H; Yi L; Huang K; Zhai Z
    Immun Inflamm Dis; 2022 May; 10(5):e616. PubMed ID: 35478441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absolute monocytosis at diagnosis correlates with survival in diffuse large B-cell lymphoma-possible link with monocytic myeloid-derived suppressor cells.
    Tadmor T; Fell R; Polliack A; Attias D
    Hematol Oncol; 2013 Jun; 31(2):65-71. PubMed ID: 22714941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-cell defect in diffuse large B-cell lymphomas involves expansion of myeloid-derived suppressor cells.
    Azzaoui I; Uhel F; Rossille D; Pangault C; Dulong J; Le Priol J; Lamy T; Houot R; Le Gouill S; Cartron G; Godmer P; Bouabdallah K; Milpied N; Damaj G; Tarte K; Fest T; Roussel M
    Blood; 2016 Aug; 128(8):1081-92. PubMed ID: 27338100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of peripheral monocytic myeloid-derived suppressor cells and monocytes in patients newly diagnosed with diffuse large b-cell lymphoma.
    Wu C; Wu X; Zhang X; Chai Y; Guo Q; Li L; Yue L; Bai J; Wang Z; Zhang L
    Int J Clin Exp Med; 2015; 8(9):15173-81. PubMed ID: 26629001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-9 promotes cell survival and drug resistance in diffuse large B-cell lymphoma.
    Lv X; Feng L; Ge X; Lu K; Wang X
    J Exp Clin Cancer Res; 2016 Jul; 35(1):106. PubMed ID: 27364124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prognostic Value of CD14
    Wu CX; Qiang M; Hao JQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Jun; 27(3):816-819. PubMed ID: 31204937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Significance of Monocytes and Monocytic Myeloid-Derived Suppressor Cells in Diffuse Large B-Cell Lymphoma Treated with R-CHOP.
    Wu C; Wu X; Liu X; Yang P; Xu J; Chai Y; Guo Q; Wang Z; Zhang L
    Cell Physiol Biochem; 2016; 39(2):521-30. PubMed ID: 27383764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent accumulation of circulating monocytic myeloid-derived suppressor cells contributes to post-infectious immunosuppression in renal transplant recipients with bacterial infection: A pilot study.
    Jiang Y; Feng S; Ji J; Lin Z; Zhang X
    Transpl Immunol; 2018 Jun; 48():10-17. PubMed ID: 29477752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Relevance and Immunosuppressive Pattern of Circulating and Infiltrating Subsets of Myeloid-Derived Suppressor Cells (MDSCs) in Epithelial Ovarian Cancer.
    Okła K; Czerwonka A; Wawruszak A; Bobiński M; Bilska M; Tarkowski R; Bednarek W; Wertel I; Kotarski J
    Front Immunol; 2019; 10():691. PubMed ID: 31001284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-33 inhibits the differentiation and immunosuppressive activity of granulocytic myeloid-derived suppressor cells in tumor-bearing mice.
    Lim HX; Choi S; Cho D; Kim TS
    Immunol Cell Biol; 2017 Jan; 95(1):99-107. PubMed ID: 27507556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myeloid-Derived Suppressor Cells Impair B Cell Responses in Lung Cancer through IL-7 and STAT5.
    Wang Y; Schafer CC; Hough KP; Tousif S; Duncan SR; Kearney JF; Ponnazhagan S; Hsu HC; Deshane JS
    J Immunol; 2018 Jul; 201(1):278-295. PubMed ID: 29752311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin 33 in tumor microenvironment is crucial for the accumulation and function of myeloid-derived suppressor cells.
    Xiao P; Wan X; Cui B; Liu Y; Qiu C; Rong J; Zheng M; Song Y; Chen L; He J; Tan Q; Wang X; Shao X; Liu Y; Cao X; Wang Q
    Oncoimmunology; 2016; 5(1):e1063772. PubMed ID: 26942079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polarization of granulocytic myeloid-derived suppressor cells by hepatitis C core protein is mediated via IL-10/STAT3 signalling.
    Wang M; Ping Y; Li Z; Li J; Zhang Z; Yue D; Chen X; Wang L; Huang L; Huang J; Yang L; Zhao X; Yang S; Li H; Shi J; Li J; Zhang Y
    J Viral Hepat; 2019 Feb; 26(2):246-257. PubMed ID: 30339295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor Microenvironment and Checkpoint Molecules in Primary Cutaneous Diffuse Large B-Cell Lymphoma-New Therapeutic Targets.
    Mitteldorf C; Berisha A; Pfaltz MC; Broekaert SMC; Schön MP; Kerl K; Kempf W
    Am J Surg Pathol; 2017 Jul; 41(7):998-1004. PubMed ID: 28504999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The prognostic impact of diabetic mellitus and hyperglycemia during DLBCL treatment on patients with diffuse large B-cell lymphoma].
    Hu Y; Xu YJ; Li MZ; Lan YX; Mao L; Ning QY; Xu W; Yang HL; Zhang YZ
    Zhonghua Xue Ye Xue Za Zhi; 2021 Feb; 42(2):151-157. PubMed ID: 33858047
    [No Abstract]   [Full Text] [Related]  

  • 18. Increased circulating CD14(+)HLA-DR-/low myeloid-derived suppressor cells are associated with poor prognosis in patients with small-cell lung cancer.
    Tian T; Gu X; Zhang B; Liu Y; Yuan C; Shao L; Guo Y; Fan K
    Cancer Biomark; 2015; 15(4):425-32. PubMed ID: 25792471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accumulation of myeloid-derived suppressor cells (MDSCs) induced by low levels of IL-6 correlates with poor prognosis in bladder cancer.
    Yang G; Shen W; Zhang Y; Liu M; Zhang L; Liu Q; Lu HH; Bo J
    Oncotarget; 2017 Jun; 8(24):38378-38388. PubMed ID: 28418913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histamine targets myeloid-derived suppressor cells and improves the anti-tumor efficacy of PD-1/PD-L1 checkpoint blockade.
    Grauers Wiktorin H; Nilsson MS; Kiffin R; Sander FE; Lenox B; Rydström A; Hellstrand K; Martner A
    Cancer Immunol Immunother; 2019 Feb; 68(2):163-174. PubMed ID: 30315349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.